Quantamental Technologies LLC Clovis Oncology, Inc. Transaction History

Quantamental Technologies LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $83,937 - $459,694	-27,979 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$3.93 - $15.35 $96,021 - $375,046	24,433 Added 689.03%	27,979 $110,000
Q2 2019 Aug 12, 2019	BUY	$12.81 - $25.67 $45,424 - $91,025	3,546 New	3,546 $53,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.